-
A Review of Indirect Costs Within Economic Appraisals in France
Sep 9, 2025, 16:22 PM -
Assessing Bias in LLM-Extracted Real-World Data: A Health Equity Analysis of Access to Care and Outcomes in Metastatic Breast Cancer
Sep 9, 2025, 16:22 PM -
The AI-in-RWE Transparency (AIRT) Checklist: Essential and Desirable Standards for AI-Enhanced Real-World Evidence
Sep 9, 2025, 16:22 PM -
Preliminary Observational Analysis of Digital Health Platform Associated With Medical Cost Changes in Employer Population
Sep 9, 2025, 16:22 PM -
An Exploration of the Incidence Rate of Anxiety and Depression Following a Diagnosis of Osteoarthritis Using the THIN Dataset
Sep 9, 2025, 16:22 PM -
What Prompt Engineering Missed and How Context Engineering Fixes It
Sep 9, 2025, 16:22 PM -
Mapping the Landscape of Digital Healthcare Services Delivered by Specialized Oncology Hospitals in China: Qualitative Analytical Study
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Iptacopan for Adult Patients With Paroxysmal Nocturnal Hemoglobinuria Previously Treated With C5 Inhibitor in the Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Durable Medical Equipment and Ancillary Service Use in Rett Syndrome Management: A Global Comprehensive Review of Literature
Sep 9, 2025, 16:22 PM -
Prognostic Factor Evaluation for Clinical Outcomes in HER2-Mutant NSCLC
Sep 9, 2025, 16:22 PM -
Comparative Effectiveness of Alectinib vs. Crizotinib as First-Line Therapy in ALK-Positive Non-Small Cell Lung Cancer: A Real-World Quasi-Experimental Study
Sep 9, 2025, 16:22 PM -
Optimizing MASLD Follow-up Strategies Under Adherence Uncertainty: A Game Theory and Signaling Approach
Sep 9, 2025, 16:22 PM -
Development of a Markov Model-Based Visualization Tool of Regional HPV Vaccination Coverage Rates Over Time in Austria: Combining Data From Pharmaceutical Industry and Healthcare Data Including National Vaccination Registry
Sep 9, 2025, 16:22 PM -
Incorporating Equity-of-Access Into Health Economic Evaluations: Surgical Task-Shifting for C-Sections in Sierra Leone
Sep 9, 2025, 16:22 PM -
Differences in the Reimbursement Pathway for Ultraorphan Therapies in England and Ireland
Sep 9, 2025, 16:22 PM -
A Real-World Study of Healthcare Resource Utilization (HCRU) and Associated Healthcare Costs for Patients With Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC) in Taiwan
Sep 9, 2025, 16:22 PM -
Intra-Procedure Cost Variability: A Retrospective Analysis of Real-World Patient Level Information Costing (PLICS) Data for a Minimally Invasive BPO Therapy in the NHS
Sep 9, 2025, 16:22 PM -
Real-World Evidence Study on Healthcare Resource Utilization (HCRU) Among Cancer Patients in the Helsinki and Uusimaa (HUS) Region, Finland
Sep 9, 2025, 16:22 PM -
Budgetary Impact of Ultra-Rare Diseases in Brazil: A Review of Decisions From the Past Five Years
Sep 9, 2025, 16:22 PM -
Integrating Patient-Reported Outcome Measures and Patient Experience Into Health Technology Assessment: A Path Towards Patient-Centered Decision Making
Sep 9, 2025, 16:22 PM
